Literature DB >> 19028867

Neonatal protection by an innate immune system of human milk consisting of oligosaccharides and glycans.

D S Newburg1.   

Abstract

This review discusses the role of human milk glycans in protecting infants, but the conclusion that the human milk glycans constitute an innate immune system whereby the mother protects her offspring may have general applicability in all mammals, including species of commercial importance. Infants that are not breastfed have a greater incidence of severe diarrhea and respiratory diseases than those who are breastfed. In the past, this had been attributed primarily to human milk secretory antibodies. However, the oligosaccharides are major components of human milk, and milk is also rich in other glycans, including glycoproteins, mucins, glycosaminoglycans, and glycolipids. These milk glycans, especially the oligosaccharides, are composed of thousands of components. The milk factor that promotes gut colonization by Bifidobacterium bifidum was found to be a glycan, and such prebiotic characteristics may contribute to protection against infectious agents. However, the ability of human milk glycans to protect the neonate seems primarily to be due to their inhibition of pathogen binding to their host cell target ligands. Many such examples include specific fucosylated oligosaccharides and glycans that inhibit specific pathogens. Most human milk oligosaccharides are fucosylated, and their production depends on fucosyltransferase enzymes; mutations in these fucosyltransferase genes are common and underlie the various Lewis blood types in humans. Variable expression of specific fucosylated oligosaccharides in milk, also a function of these genes (and maternal Lewis blood type), is significantly associated with the risk of infectious disease in breastfed infants. Human milk also contains major quantities and large numbers of sialylated oligosaccharides, many of which are also present in bovine colostrum. These could similarly inhibit several common viral pathogens. Moreover, human milk oligosaccharides strongly attenuate inflammatory processes in the intestinal mucosa. These results support the hypothesis that oligosaccharides and other glycans are the major constituents of an innate immune system of human milk whereby the mother protects her infant from enteric and other pathogens through breastfeeding. These protective glycans may prove useful as a basis for the development of novel prophylactic and therapeutic agents that inhibit disease by mucosal pathogens in many species.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19028867     DOI: 10.2527/jas.2008-1347

Source DB:  PubMed          Journal:  J Anim Sci        ISSN: 0021-8812            Impact factor:   3.159


  78 in total

Review 1.  Progress and challenges in developing metabolic footprints from diet in human gut microbial cometabolism.

Authors:  Linda C Duffy; Daniel J Raiten; Van S Hubbard; Pamela Starke-Reed
Journal:  J Nutr       Date:  2015-04-01       Impact factor: 4.798

2.  Introduction to the symposium.

Authors:  Clemens Kunz; Gyula Dekany; Christoph H Röhrig; Sharon M Donovan
Journal:  Adv Nutr       Date:  2012-05-01       Impact factor: 8.701

Review 3.  Bioengineered bugs expressing oligosaccharide receptor mimics: toxin-binding probiotics for treatment and prevention of enteric infections.

Authors:  Adrienne W Paton; Renato Morona; James C Paton
Journal:  Bioeng Bugs       Date:  2009-11-17

Review 4.  Our microbial selves: what ecology can teach us.

Authors:  Antonio Gonzalez; Jose C Clemente; Ashley Shade; Jessica L Metcalf; Sejin Song; Bharath Prithiviraj; Brent E Palmer; Rob Knight
Journal:  EMBO Rep       Date:  2011-07-01       Impact factor: 8.807

5.  Improvement of the transfucosylation activity of α-L-fucosidase from Thermotoga maritima for the synthesis of fucosylated oligosaccharides in the presence of calcium and sodium.

Authors:  Francisco Guzmán-Rodríguez; Sergio Alatorre-Santamaría; Lorena Gómez-Ruiz; Gabriela Rodríguez-Serrano; Mariano García-Garibay; Alma Cruz-Guerrero
Journal:  Extremophiles       Date:  2018-08-07       Impact factor: 2.395

Review 6.  Intestinal microbiota and faecal transplantation as treatment modality for insulin resistance and type 2 diabetes mellitus.

Authors:  S D Udayappan; A V Hartstra; G M Dallinga-Thie; M Nieuwdorp
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

Review 7.  The Human Milk Glycome as a Defense Against Infectious Diseases: Rationale, Challenges, and Opportunities.

Authors:  Kelly M Craft; Steven D Townsend
Journal:  ACS Infect Dis       Date:  2017-11-15       Impact factor: 5.084

8.  Infectious Morbidity, Mortality and Nutrition in HIV-exposed, Uninfected, Formula-fed Infants: Results From the HPTN 040/PACTG 1043 Trial.

Authors:  Nava Yeganeh; D Heather Watts; Jiahong Xu; Tara Kerin; Esau C Joao; Jose Henrique Pilotto; Gerhard Theron; Glenda Gray; Breno Santos; Rosana Fonseca; Regis Kreitchmann; Jorge Pinto; Marisa M Mussi-Pinhata; Valdilea Veloso; Margaret Camarca; Lynne Mofenson; Jack Moye; Karin Nielsen-Saines
Journal:  Pediatr Infect Dis J       Date:  2018-12       Impact factor: 2.129

Review 9.  Pathogenesis of NEC: Role of the innate and adaptive immune response.

Authors:  Timothy L Denning; Amina M Bhatia; Andrea F Kane; Ravi M Patel; Patricia W Denning
Journal:  Semin Perinatol       Date:  2016-12-09       Impact factor: 3.300

10.  Association of breastfeeding with asthma in young Aboriginal children in Canada.

Authors:  Ming Ye; Piushkumar J Mandhane; Ambikaipakan Senthilselvan
Journal:  Can Respir J       Date:  2012 Nov-Dec       Impact factor: 2.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.